English

MAIO, 23 e 24
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PERFIL DOS PARTICIPANTES

Categorias de produtos

Branded generics: 48.3%
96.6

Biological products: 34.5%
69

Biosimilars: 20.7%
41.4

Hospital products: 34.5%
69

Innovative medicines: 55.0%
110

mais informações




Interesses estratégicos

In-licensing: 55.2%
110.4

Out-licensing: 46.6%
93.2

Co-marketing: 37.9%
75.8

Co-promotion: 37.9%
75.8

Co-development: 53.4%
106.8

mais informações




Área terapêutica

Cardiovascular: 51.7%
103.4

CNS: 50.0%
100

Infectious diseases: 32.8%
65.6

Pain: 48.3%
96.6

Respiratory: 36.2%
72.4

mais informações



PARTICIPANTES 2019

In-licensing: 55.2%

Out-licensing: 46.6%

Co-marketing: 37.9%

Co-promotion: 37.9%

Co-development: 53.4%

Technology transfer: 28.4%

Outsourcing: 13.8%

Others: 21.6%

Patrocinador

patrocinador

apoio